Pediatric ARDS Trial Stopped Early Due to Futility

An international Phase 3 clinical trial (PROSpect) investigating prone positioning and high-frequency oscillatory ventilation (HFOV) for early pediatric acute respiratory distress syndrome (ARDS) was halted prematurely due to futility and slow enrollment. The study, published in The Lancet, found no significant benefit from prone positioning and noted more hemodynamic instability with HFOV. This outcome suggests these interventions may not improve ventilator-free days in pediatric ARDS, guiding future treatment strategies.